Treatment of experimental asthma by decoy-mediated local inhibition of activator protein-1.
about
Derivation and validation of murine histologic alterations resembling asthma, with two proposed histologic grade parameters.Untargeted Proteomics and Systems-Based Mechanistic Investigation of Artesunate in Human Bronchial Epithelial Cells.Activation of the transcription factor FosB/activating protein-1 (AP-1) is a prominent downstream signal of the extracellular nucleotide receptor P2RX7 in monocytic and osteoblastic cells.Differential induction of CD38 expression by TNF-{alpha} in asthmatic airway smooth muscle cells.A disease module in the interactome explains disease heterogeneity, drug response and captures novel pathways and genes in asthmaHaploinsufficiency for Stard7 is associated with enhanced allergic responses in lung and skin.Update in asthma 2005.New drugs targeting Th2 lymphocytes in asthma.Cell signaling via the P2X(7) nucleotide receptor: linkage to ROS production, gene transcription, and receptor traffickingPreventive and therapeutic anti-inflammatory properties of the sesquiterpene alpha-humulene in experimental airways allergic inflammation.Gene therapy for allergic airway diseases.The potential for genetically altered microglia to influence glioma treatment.Decoy oligodeoxynucleotide targeting activator protein-1 (AP-1) attenuates intestinal inflammation in murine experimental colitis.Decoy oligodeoxynucleotide against STAT transcription factors decreases allergic inflammation in a rat asthma model.Fra2 Overexpression in Mice Leads to Non-allergic Asthma Development in an IL-13 Dependent MannerThe Role of BACH2 in T Cells in Experimental Malaria Caused by AS
P2860
Q33514105-E9BEAF7E-47C9-49BB-9545-53A7F573FB27Q33824170-60BB17AF-BF5F-49AC-A3D7-DECCF4645A4CQ34232228-3EE9F099-97A7-4885-8AD3-7CA066CB9734Q34426038-597CC267-7A50-4F6D-8279-DF0806E207ECQ35661841-28B45B83-D759-43F1-87C3-EEF8C98E3DB0Q35691045-475AA169-3D1F-4997-B920-0318E6C72DE9Q36429918-0710F30B-2F58-41D1-B74E-6C749E7BEAB7Q36485165-323A3D7C-30A4-46A7-B227-72DA40B00D85Q37203208-57D27758-8708-4795-91C1-FC2E21FED58FQ37447495-965D873E-3A49-4185-9C41-06639A36D16DQ37829670-24EB20C4-86D5-4789-BFDA-1D0D59EE6C74Q38139120-DED060F3-6F26-4CDE-B139-D5476F58B85BQ39985099-91C55F0C-83D3-4375-83D0-25127D033745Q43141763-21ECDD55-F944-4F07-BBFD-466483BEC99FQ58763011-FC347C40-B2E8-431B-A924-7ABC74700357Q59136452-EF630E53-409F-4885-978D-4FBAFD2E913C
P2860
Treatment of experimental asthma by decoy-mediated local inhibition of activator protein-1.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Treatment of experimental asth ...... bition of activator protein-1.
@en
type
label
Treatment of experimental asth ...... bition of activator protein-1.
@en
prefLabel
Treatment of experimental asth ...... bition of activator protein-1.
@en
P2093
P2860
P1476
Treatment of experimental asth ...... bition of activator protein-1.
@en
P2093
Bart Lambrecht
Bernard Pajak
Christophe Desmet
Daniel Desmecht
Dorothée Mélotte
Emmanuelle Henry
Fabrice Bureau
Fabrice Jaspar
Muriel Moser
P2860
P304
P356
10.1164/RCCM.200410-1431OC
P407
P577
2005-06-16T00:00:00Z